Literature DB >> 17183467

A change in response to Bmp signalling precedes ectodermal fate choice.

Chris T Dee1, Abigail Gibson, Andrea Rengifo, Shun-Kuo Sun, Roger K Patient, Paul J Scotting.   

Abstract

Bone morphogenetic protein (Bmp) signalling plays a central role in the decision of ectoderm to adopt either neural or non-neural fates. The effects of this signalling are seen at mid-gastrulation in the activation of genes such as the Gata factors and the repression of genes such as the SoxB1 transcription factors in the non-neural regions. Using zebrafish embryos, we show that this Bmp signalling does not repress the expression of these same neural markers just 2-3 hours earlier. Since expression of the Bmp signalling effector, Smad1, only begins during early gastrulation, we tested the role of Smad1 and Smad5 (which is maternally expressed) in controlling gene expression both before and during gastrulation. This showed that the absence of Smad1 does not explain the lack of response of neural genes to Bmp signalling at early stages. However, these experiments showed that expression of the non-neural marker, gata2, is mediated by Smad5 in the absence of Smad1 at early stages, but is dependent upon Smad1 at later stages. Hence, we have shown a dynamic change in the molecular machinery underlying the Bmp response in the ectoderm during gastrulation stages of development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17183467     DOI: 10.1387/ijdb.062204cd

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  8 in total

1.  Zebrafish Pou5f1-dependent transcriptional networks in temporal control of early development.

Authors:  Daria Onichtchouk; Florian Geier; Bozena Polok; Daniel M Messerschmidt; Rebecca Mössner; Björn Wendik; Sungmin Song; Verdon Taylor; Jens Timmer; Wolfgang Driever
Journal:  Mol Syst Biol       Date:  2010-03-09       Impact factor: 11.429

2.  Transcriptional factors smad1 and smad9 act redundantly to mediate zebrafish ventral specification downstream of smad5.

Authors:  Chang-Yong Wei; Hou-Peng Wang; Zuo-Yan Zhu; Yong-Hua Sun
Journal:  J Biol Chem       Date:  2014-01-31       Impact factor: 5.157

3.  Smad1 and Smad5 differentially regulate embryonic hematopoiesis.

Authors:  Lisa J McReynolds; Sunny Gupta; Maria E Figueroa; Mary C Mullins; Todd Evans
Journal:  Blood       Date:  2007-08-29       Impact factor: 22.113

4.  Cell communication with the neural plate is required for induction of neural markers by BMP inhibition: evidence for homeogenetic induction and implications for Xenopus animal cap and chick explant assays.

Authors:  Claudia Linker; Irene De Almeida; Costis Papanayotou; Matthew Stower; Virginie Sabado; Ehsan Ghorani; Andrea Streit; Roberto Mayor; Claudio D Stern
Journal:  Dev Biol       Date:  2009-01-03       Impact factor: 3.582

5.  The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells.

Authors:  Fabiana Perna; Ly P Vu; Maria Themeli; Sonja Kriks; Ruben Hoya-Arias; Raya Khanin; Todd Hricik; Jorge Mansilla-Soto; Eirini P Papapetrou; Ross L Levine; Lorenz Studer; Michel Sadelain; Stephen D Nimer
Journal:  Stem Cell Reports       Date:  2015-03-05       Impact factor: 7.765

6.  Scale-invariant patterning by size-dependent inhibition of Nodal signalling.

Authors:  María Almuedo-Castillo; Alexander Bläßle; David Mörsdorf; Luciano Marcon; Gary H Soh; Katherine W Rogers; Alexander F Schier; Patrick Müller
Journal:  Nat Cell Biol       Date:  2018-07-30       Impact factor: 28.824

7.  Formation of the embryonic organizer is restricted by the competitive influences of Fgf signaling and the SoxB1 transcription factors.

Authors:  Cheng-Liang Kuo; Chi Man Lam; Jane E Hewitt; Paul J Scotting
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

8.  Organizer-derived Bmp2 is required for the formation of a correct Bmp activity gradient during embryonic development.

Authors:  Yu Xue; Xiudeng Zheng; Lei Huang; Pengfei Xu; Yuanqing Ma; Zheying Min; Qinghua Tao; Yi Tao; Anming Meng
Journal:  Nat Commun       Date:  2014-04-29       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.